Spruce Biosciences (SPRB) Return on Sales (2023 - 2025)
Spruce Biosciences (SPRB) has disclosed Return on Sales for 3 consecutive years, with 67.34% as the latest value for Q3 2025.
- On a quarterly basis, Return on Sales fell 5289.0% to 67.34% in Q3 2025 year-over-year; TTM through Sep 2025 was 67.34%, a 6178.0% decrease, with the full-year FY2024 number at 10.8%, down 605.0% from a year prior.
- Return on Sales was 67.34% for Q3 2025 at Spruce Biosciences, down from 36.87% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 3.45% in Q4 2023 to a low of 67.34% in Q3 2025.
- A 3-year average of 18.39% and a median of 6.4% in 2023 define the central range for Return on Sales.
- Peak YoY movement for Return on Sales: skyrocketed 59bps in 2024, then tumbled -5289bps in 2025.
- Spruce Biosciences' Return on Sales stood at 3.45% in 2023, then plummeted by -861bps to 33.14% in 2024, then tumbled by -103bps to 67.34% in 2025.
- Per Business Quant, the three most recent readings for SPRB's Return on Sales are 67.34% (Q3 2025), 36.87% (Q2 2025), and 19.06% (Q1 2025).